Business
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of
About this update from Twist Bioscience Corporation
[{"type":"text","content":" SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nTwist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its environmental, social and governance (ESG) report for 2023, highlighting Twist’s approach to sustainability, social responsibility and commitment to ethics.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230822647314/en/Visual comparison of emissions equivalent from manufacturing a single gene using Twist Bioscience's approach versus manufacturing a single gene using a 96-well plate approach (Graphic: Business Wire)\n“We took a big step forward in our ongoing commitment to deliver sustainable solutions to our customers, quantifying the impact of our proprietary approach to making synthetic DNA,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “Last year we quantified our chemical footprint and found that our silicon chip-based approach to creating DNA uses 99.8% fewer chemicals than 96-well plate approaches1. This year, we’ve quantified the carbon footprint of manufacturing a single Twist gene compared to manufacturing a gene using a 96-well plate approach and the results are dramatic. Manufacturing one gene using the Twist method is equivalent to the emissions from driving a gas car 0.092 miles or 0.15 kilometers2. The amount of CO2e emitted using a standard 96-well plate approach is equivalent to driving 59 miles or 96 kilometers. The more sustainable synthetic DNA we provide to our customers is not new; we have just quantified the emissions impact of our proprietary approach, which then carries through to all of our customers who use our DNA for new therapies, diagnostic tests, materials, biobased chemicals, and more.”\n\n\nDr. Leproust continued, “In addition to the quantification data, we continue to exemplify good environmental, social and governance practices. We joined the United Nations Global Compact and committed to Sustainable Development Goals focused on sustainability, food security, health and gender equality. As a company, we continue to foster a diverse workforce and support career growth and development while running an ethical business with cyber and biosecurity measures in place.”\n\n\nSustainab...